Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire R M Dibben

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The British Journal of Psychiatry : the Journal of Mental Science|September 3, 2015
Hearing voices: are we getting the message?Golam M Khandaker, Claire R M Dibben, Peter B Jones
Journal of Evaluation in Clinical Practice|February 25, 2012
Evaluating care pathways for community psychiatry in England: a qualitative studyGolam M Khandaker, Praveen K Gandamaneni, Claire R M Dibben, et al.
Bjpsych Bulletin|April 19, 2016
First-generation antipsychotics: not gone but forgottenClaire R M Dibben, Golam M Khandaker, Benjamin R Underwood, et al.
BMJ Open|September 24, 2018
Protocol for the insight study: a randomised controlled trial of single-dose tocilizumab in patients with depression and low-grade inflammationGolam M Khandaker, Bianca P Oltean, Muzaffer Kaser, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The British Journal of Psychiatry : the Journal of Mental Science|September 3, 2015
Hearing voices: are we getting the message?Golam M Khandaker, Claire R M Dibben, Peter B Jones
Journal of Evaluation in Clinical Practice|February 25, 2012
Evaluating care pathways for community psychiatry in England: a qualitative studyGolam M Khandaker, Praveen K Gandamaneni, Claire R M Dibben, et al.
Bjpsych Bulletin|April 19, 2016
First-generation antipsychotics: not gone but forgottenClaire R M Dibben, Golam M Khandaker, Benjamin R Underwood, et al.
BMJ Open|September 24, 2018
Protocol for the insight study: a randomised controlled trial of single-dose tocilizumab in patients with depression and low-grade inflammationGolam M Khandaker, Bianca P Oltean, Muzaffer Kaser, et al.
Pageof 1